Nb. Countryman et al., Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production, J INVES DER, 115(2), 2000, pp. 267-272
Ultraviolet B radiation has been shown to generate cutaneous inflammation i
n part through inducing oxidative stress and cytokine production in human k
eratinocytes. Amongst the proinflammatory cytokines synthesized in response
to ultraviolet B radiation is the potent chemoattractant interleukin-8. Th
ough the lipid mediator platelet-activating factor (PAF) is synthesized in
response to oxidative stress, and keratinocytes express PAF receptors linke
d to cytokine biosynthesis, it is not known whether PAF is involved in ultr
aviolet-B-induced epidermal cell cytokine production. These studies examine
d the role of the PAF system in ultraviolet-B-induced epidermal cell interl
eukin-8 biosynthesis using a novel model system created by retroviral-media
ted transduction of the PAF-receptor-negative human epidermal cell line KB
with the human PAF receptor. Treatment of PAF-receptor-expressing KB cells
with the metabolically stable PAF receptor agonist carbamoyl-PAF resulted i
n increased interleukin-8 mRNA and protein, indicating that activation of t
he epidermal PAF receptor was linked to interleukin-8 production. Ultraviol
et B irradiation of PAF-receptor-expressing KB cells resulted in significan
t increases in both interleukin-8 mRNA and protein in comparison to ultravi
olet-B-treated control KB cells. Pretreatment with PAF receptor antagonists
inhibited both carbamoyl-PAF-induced and ultraviolet-B-induced interleukin
-8 production in the PAF-receptor-positive cells, but not in control KB cel
ls. Similarly, treatment of the PAF-receptor-expressing primary cultures of
human keratinocytes or the human epidermal cell line A-431 with carbamoyl-
PAF or ultraviolet B radiation resulted in interleukin-8 production that wa
s partially inhibited by PAF receptor antagonists. These studies suggest th
at the epidermal PAF receptor may be a pharmacologic target for ultraviolet
B radiation in skin and thus may act to augment ultraviolet-B-mediated pro
duction of cytokines such as interleukin-8.